Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid ? from the human brain
Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid ? from the human brain
Accumulation of amyloid ? (A?) in the extracellular spaces of the cerebral cortex and in blood vessel walls as cerebral amyloid angiopathy is a characteristic of Alzheimer's disease (AD) and the ageing human brain. Studies in animals suggest that A? is eliminated from the brain either directly into the blood or along perivascular interstitial fluid drainage channels. The aim of the present study is to define the perivascular route for the drainage of A? from the human brain. Smears and paraffin sections of post-mortem cortical tissue from 17 cases of AD and from two controls were stained with thioflavin and for A? by immunohistochemistry. Histology and confocal microscopy showed that deposits of A? in the cortical parenchyma were continuous with A? in capillary walls but A? in artery walls was not in continuity with A? in brain parenchyma. Quantitative studies supported these observations. The results of this study suggest that when A? is eliminated from the extracellular spaces of the human brain by the perivascular route, it enters pericapillary spaces and from there drains along the walls of cortical arteries to leptomeningeal arteries. Factors such as overproduction of A?, entrapment of A? in drainage pathways and poor drainage of A? due to functional changes in ageing arteries might result in the failure of elimination of A? from the ageing brain and play a major role in the pathogenesis of AD. Such factors might affect therapies for AD that entail administration of anti-A? antibodies to eliminate A? from the human brain.
106-117
Preston, S.D.
0b358288-808c-4fc4-b7c6-bd9820eba1d9
Steart, P.V.
63ec5626-b565-456a-87b6-7e5f09d4ec21
Wilkinson, A.
3851aaac-7947-4c2f-9ce7-ee41189599e2
Nicoll, J.A.R.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
Weller, R.O.
4a501831-e38a-4d39-a125-d7141d6c667b
2003
Preston, S.D.
0b358288-808c-4fc4-b7c6-bd9820eba1d9
Steart, P.V.
63ec5626-b565-456a-87b6-7e5f09d4ec21
Wilkinson, A.
3851aaac-7947-4c2f-9ce7-ee41189599e2
Nicoll, J.A.R.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
Weller, R.O.
4a501831-e38a-4d39-a125-d7141d6c667b
Preston, S.D., Steart, P.V., Wilkinson, A., Nicoll, J.A.R. and Weller, R.O.
(2003)
Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid ? from the human brain.
Neuropathology & Applied Neurobiology, 29 (2), .
(doi:10.1046/j.1365-2990.2003.00424.x).
Abstract
Accumulation of amyloid ? (A?) in the extracellular spaces of the cerebral cortex and in blood vessel walls as cerebral amyloid angiopathy is a characteristic of Alzheimer's disease (AD) and the ageing human brain. Studies in animals suggest that A? is eliminated from the brain either directly into the blood or along perivascular interstitial fluid drainage channels. The aim of the present study is to define the perivascular route for the drainage of A? from the human brain. Smears and paraffin sections of post-mortem cortical tissue from 17 cases of AD and from two controls were stained with thioflavin and for A? by immunohistochemistry. Histology and confocal microscopy showed that deposits of A? in the cortical parenchyma were continuous with A? in capillary walls but A? in artery walls was not in continuity with A? in brain parenchyma. Quantitative studies supported these observations. The results of this study suggest that when A? is eliminated from the extracellular spaces of the human brain by the perivascular route, it enters pericapillary spaces and from there drains along the walls of cortical arteries to leptomeningeal arteries. Factors such as overproduction of A?, entrapment of A? in drainage pathways and poor drainage of A? due to functional changes in ageing arteries might result in the failure of elimination of A? from the ageing brain and play a major role in the pathogenesis of AD. Such factors might affect therapies for AD that entail administration of anti-A? antibodies to eliminate A? from the human brain.
This record has no associated files available for download.
More information
Published date: 2003
Identifiers
Local EPrints ID: 27688
URI: http://eprints.soton.ac.uk/id/eprint/27688
PURE UUID: f55d588f-6a53-4da8-8119-82fb26f96a65
Catalogue record
Date deposited: 28 Apr 2006
Last modified: 16 Mar 2024 03:26
Export record
Altmetrics
Contributors
Author:
S.D. Preston
Author:
P.V. Steart
Author:
A. Wilkinson
Author:
R.O. Weller
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics